Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia
暂无分享,去创建一个
M. Tremblay | M. Naujokas | Morag Park | R. Vaillancourt | M. Stuible | D. Zuo | Kossay Zaoui | S. Havrylov | C. Rajadurai
[1] S. Courtneidge,et al. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function , 2011, Nature Reviews Molecular Cell Biology.
[2] Z. Kouchi,et al. Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation , 2011, The Journal of cell biology.
[3] Takayuki Kosaka,et al. Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer , 2011, Journal of biomedicine & biotechnology.
[4] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[5] Thinzar M. Lwin,et al. Twist1-induced invadopodia formation promotes tumor metastasis. , 2011, Cancer cell.
[6] J. Condeelis,et al. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. , 2011, Cancer research.
[7] A. Boggs,et al. c-Src differentially regulates the functions of microtentacles and invadopodia , 2010, Oncogene.
[8] S. Weed,et al. Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation , 2010, Journal of Cell Science.
[9] J. Condeelis,et al. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia , 2010, Journal of Cell Science.
[10] I. Pichot,et al. Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp. , 2010, Cancer research.
[11] A. Pendergast,et al. Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion* , 2010, The Journal of Biological Chemistry.
[12] H. Yamaguchi,et al. Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis , 2010, Oncotarget.
[13] B. Blagoev,et al. PTP1B Targets the Endosomal Sorting Machinery , 2010, The Journal of Biological Chemistry.
[14] Robert D. Goldman,et al. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia , 2010, The Journal of cell biology.
[15] Kimito Yamada,et al. Epidermal growth factor‐dependent enhancement of invasiveness of squamous cell carcinoma of the breast , 2010, Cancer science.
[16] Morag Park,et al. The Gab1 scaffold regulates RTK-dependent dorsal ruffle formation through the adaptor Nck , 2010, Journal of Cell Science.
[17] A. Brunati,et al. Recognition of lysine‐rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies , 2009, Biopolymers.
[18] Morag Park,et al. Crosstalk in Met receptor oncogenesis. , 2009, Trends in cell biology.
[19] M. Gimona,et al. Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation. , 2009, Experimental cell research.
[20] Jacco van Rheenen,et al. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation , 2009, The Journal of cell biology.
[21] R. Cardiff,et al. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer , 2009, Proceedings of the National Academy of Sciences.
[22] S. Stylli,et al. Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation , 2009, Journal of Cell Science.
[23] J. Condeelis,et al. N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. , 2009, Cell motility and the cytoskeleton.
[24] T. Takenawa,et al. PtdIns(3,4)P2 instigates focal adhesions to generate podosomes , 2009, Cell adhesion & migration.
[25] V. Castronovo,et al. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is up-regulated in prostate and breast cancer. , 2009, Cancer research.
[26] R. Buccione,et al. Invadopodia: specialized tumor cell structures for the focal degradation of the extracellular matrix , 2009, Cancer and Metastasis Reviews.
[27] H. Sasaki,et al. Met gene copy number predicts the prognosis for completely resected non‐small cell lung cancer , 2008, Cancer science.
[28] I. Pass,et al. A role for the podosome/invadopodia scaffold protein Tks5 in tumor growth in vivo. , 2008, European journal of cell biology.
[29] Alissa M. Weaver,et al. A new role for cortactin in invadopodia: regulation of protease secretion. , 2008, European journal of cell biology.
[30] T. Takenawa,et al. Sequential signals toward podosome formation in NIH-src cells , 2008, The Journal of cell biology.
[31] M. Tremblay,et al. PTP1B Regulates Cortactin Tyrosine Phosphorylation by Targeting Tyr446* , 2008, Journal of Biological Chemistry.
[32] J. Tuynman,et al. Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma , 2008, British Journal of Cancer.
[33] A. Huttenlocher,et al. Calpain 2 and PTP1B function in a novel pathway with Src to regulate invadopodia dynamics and breast cancer cell invasion , 2008, The Journal of cell biology.
[34] M. Naujokas,et al. Gab2 requires membrane targeting and the met binding motif to promote lamellipodia, cell scatter, and epithelial morphogenesis downstream from the met receptor , 2008, Journal of cellular physiology.
[35] M. Gimona. The microfilament system in the formation of invasive adhesions. , 2008, Seminars in cancer biology.
[36] P. Comoglio,et al. The MET receptor tyrosine kinase in invasion and metastasis , 2007, Journal of cellular physiology.
[37] P. Timpson,et al. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib. , 2007, Cancer research.
[38] Alissa M. Weaver,et al. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. , 2007, Cancer research.
[39] M. Weiser,et al. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. , 2007, Cancer letters.
[40] B. Webb,et al. Dissecting the functional domain requirements of cortactin in invadopodia formation. , 2007, European journal of cell biology.
[41] S. Linder. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. , 2007, Trends in cell biology.
[42] M. Park,et al. From Tpr-Met to Met, tumorigenesis and tubes , 2007, Oncogene.
[43] E. Kistner,et al. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. , 2007, Cancer research.
[44] Y. Onodera,et al. CIN85, a Cbl‐interacting protein, is a component of AMAP1‐mediated breast cancer invasion machinery , 2007, The EMBO journal.
[45] András Kapus,et al. Cortactin: the gray eminence of the cytoskeleton. , 2006, Physiology.
[46] Rebecca Slack,et al. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. , 2006, Experimental cell research.
[47] Françoise Seillier-Moiseiwitsch,et al. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. , 2006, Cancer research.
[48] P. Comoglio,et al. Cancer therapy: can the challenge be MET? , 2005, Trends in molecular medicine.
[49] E. Lengyel,et al. C‐Met overexpression in node‐positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu , 2005, International journal of cancer.
[50] J. Resau,et al. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. , 2005, Cancer cell.
[51] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[52] J. Christensen,et al. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. , 2003, Cancer research.
[53] Morag Park,et al. Grb2-independent Recruitment of Gab1 Requires the C-terminal Lobe and Structural Integrity of the Met Receptor Kinase Domain* , 2003, Journal of Biological Chemistry.
[54] Marina Holgado-Madruga,et al. Gab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress , 2003, Molecular and Cellular Biology.
[55] J. Reis-Filho,et al. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas , 2003, Oncology.
[56] C. Maroun,et al. Distinct recruitment and function of Gab1 and Gab2 in Met receptor-mediated epithelial morphogenesis. , 2002, Molecular biology of the cell.
[57] D. Schlaepfer,et al. v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.
[58] M. Naujokas,et al. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis , 2002, Oncogene.
[59] Jie Wu,et al. Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2* , 2001, The Journal of Biological Chemistry.
[60] Roger Williams,et al. Hepatocyte Growth Factor/Scatter Factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner , 2001, Oncogene.
[61] Peijun Zhang,et al. Activation of Arp2/3 complex-mediated actin polymerization by cortactin , 2001, Nature Cell Biology.
[62] D. Kamikura,et al. A switch from p130Cas/Crk to Gab1/Crk signaling correlates with anchorage independent growth and JNK activation in cells transformed by the Met receptor oncoprotein , 2000, Oncogene.
[63] C. Maroun,et al. The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase , 2000, Molecular and Cellular Biology.
[64] M. Naujokas,et al. Identification of an Atypical Grb2 Carboxyl-terminal SH3 Domain Binding Site in Gab Docking Proteins Reveals Grb2-dependent and -independent Recruitment of Gab1 to Receptor Tyrosine Kinases* , 2000, The Journal of Biological Chemistry.
[65] W. Birchmeier,et al. Coupling of Gab1 to C-Met, Grb2, and Shp2 Mediates Biological Responses , 2000, The Journal of cell biology.
[66] P. Comoglio,et al. Sustained recruitment of phospholipase C-γ to Gab1 is required for HGF-induced branching tubulogenesis , 2000, Oncogene.
[67] K. Vuori,et al. Met-induced JNK activation is mediated by the adapter protein Crk and correlates with the Gab1 – Crk signaling complex formation , 1999, Oncogene.
[68] E. Rimm,et al. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma , 1999, Cancer.
[69] D. Thomas,et al. An invasion-related complex of cortactin, paxillin and PKCμ associates with invadopodia at sites of extracellular matrix degradation , 1999, Oncogene.
[70] Morag Park,et al. The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase , 1999, Molecular and Cellular Biology.
[71] C. Chi,et al. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. , 1998, Oncology reports.
[72] M. Tremblay,et al. Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356* , 1997, The Journal of Biological Chemistry.
[73] D. Kamikura,et al. Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1* , 1997, The Journal of Biological Chemistry.
[74] W. Birchmeier,et al. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.
[75] D. Kamikura,et al. Branching Tubulogenesis but Not Scatter of Madin-Darby Canine Kidney Cells Requires a Functional Grb2 Binding Site in the Met Receptor Tyrosine Kinase* , 1996, The Journal of Biological Chemistry.
[76] A. Bardelli,et al. Specific Uncoupling of GRB2 from the Met Receptor , 1996, The Journal of Biological Chemistry.
[77] D. Kamikura,et al. Pathways Downstream of Shc and Grb2 Are Required for Cell Transformation by the Tpr-Met Oncoprotein* , 1996, The Journal of Biological Chemistry.
[78] A. Sparks,et al. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] M. Moran,et al. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. , 1995, Oncogene.
[80] A. Bardelli,et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.
[81] T. Urano,et al. Expression of hepatocyte growth factor(hgf) and C-met gene in human gastric-cancer cell-lines. , 1993, International journal of oncology.
[82] M. Naujokas,et al. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing , 1991, Molecular and cellular biology.
[83] W. T. Chen,et al. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. , 1989, The Journal of experimental zoology.
[84] J. Segall,et al. Molecular mechanisms of invadopodium formation: the role of the N-WASP–Arp2/3 complex pathway and cofilin , 2005 .